Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma

Mitsuhiro Shirakawa, Yoshiyuki Fujiwara, Yurika Sugita, Jeong Ho Moon, Shuji Takiguchi, Kiyokazu Nakajima, Hiroshi Miyata, Makoto Yamasaki, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Stanniocalcin-1 (STC1) is a secreted glycoprotein hormone and highly expressed in various types of human malignancies. Although evidence points to the role of STC1 in human cancers, the clinical significance of STC1 expression in esophageal cancer has not been well established. Quantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry were performed to assess the expression of STC1 in the cancer cell line TE8 and esophageal cancer tissues from 229 esophageal squamous cell carcinomas (ESCC). Surgically-resected tissue sections were immunostained for potential regulators of STC1 expression, hypoxia-inducible factor-1α (HIF-1α) and p53. Marked increase in STC1 mRNA and protein expression was noted in TE8 cells cultured under hypoxic conditions. Overexpression of STC1 mRNA was noted in ESCC tumors compared to normal counterparts. Positive immunohistochemical staining for STC1 protein was observed in 38.9% of patients, and correlated significantly with advanced pT status (P=0.019), poor prognosis [overall survival (P<0.0006) and disease-free survival (P<0.0002) of ESCC patients who had undergone curative surgery]. Positive staining for HIF-1α and p53 proteins in ESCC did not correlate with STC1 expression. The results showed marked induction of STC1 expression under hypoxia in cultured cells and in esophageal cancer cells and that overexpression of STC1 was an independent prognostic factor in patients with esophageal cancer who had undergone curative surgery. STC1 is a potentially useful biomarker for ESCC treatment.

Original languageEnglish
Pages (from-to)940-946
Number of pages7
JournalOncology reports
Volume27
Issue number4
DOIs
Publication statusPublished - Apr 1 2012

Fingerprint

Esophageal Neoplasms
Hypoxia-Inducible Factor 1
teleocalcin
Esophageal Squamous Cell Carcinoma
Cultured Cells
Neoplasms
Staining and Labeling
Messenger RNA
Proteins
Reverse Transcriptase Polymerase Chain Reaction
Disease-Free Survival
Glycoproteins
Biomarkers
Immunohistochemistry
Hormones
Cell Line
Survival
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Shirakawa, M., Fujiwara, Y., Sugita, Y., Moon, J. H., Takiguchi, S., Nakajima, K., ... Doki, Y. (2012). Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma. Oncology reports, 27(4), 940-946. https://doi.org/10.3892/or.2011.1607

Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma. / Shirakawa, Mitsuhiro; Fujiwara, Yoshiyuki; Sugita, Yurika; Moon, Jeong Ho; Takiguchi, Shuji; Nakajima, Kiyokazu; Miyata, Hiroshi; Yamasaki, Makoto; Mori, Masaki; Doki, Yuichiro.

In: Oncology reports, Vol. 27, No. 4, 01.04.2012, p. 940-946.

Research output: Contribution to journalArticle

Shirakawa, M, Fujiwara, Y, Sugita, Y, Moon, JH, Takiguchi, S, Nakajima, K, Miyata, H, Yamasaki, M, Mori, M & Doki, Y 2012, 'Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma', Oncology reports, vol. 27, no. 4, pp. 940-946. https://doi.org/10.3892/or.2011.1607
Shirakawa M, Fujiwara Y, Sugita Y, Moon JH, Takiguchi S, Nakajima K et al. Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma. Oncology reports. 2012 Apr 1;27(4):940-946. https://doi.org/10.3892/or.2011.1607
Shirakawa, Mitsuhiro ; Fujiwara, Yoshiyuki ; Sugita, Yurika ; Moon, Jeong Ho ; Takiguchi, Shuji ; Nakajima, Kiyokazu ; Miyata, Hiroshi ; Yamasaki, Makoto ; Mori, Masaki ; Doki, Yuichiro. / Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma. In: Oncology reports. 2012 ; Vol. 27, No. 4. pp. 940-946.
@article{bc514ce7a4924c4b8d0f8bdb791c2d2e,
title = "Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma",
abstract = "Stanniocalcin-1 (STC1) is a secreted glycoprotein hormone and highly expressed in various types of human malignancies. Although evidence points to the role of STC1 in human cancers, the clinical significance of STC1 expression in esophageal cancer has not been well established. Quantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry were performed to assess the expression of STC1 in the cancer cell line TE8 and esophageal cancer tissues from 229 esophageal squamous cell carcinomas (ESCC). Surgically-resected tissue sections were immunostained for potential regulators of STC1 expression, hypoxia-inducible factor-1α (HIF-1α) and p53. Marked increase in STC1 mRNA and protein expression was noted in TE8 cells cultured under hypoxic conditions. Overexpression of STC1 mRNA was noted in ESCC tumors compared to normal counterparts. Positive immunohistochemical staining for STC1 protein was observed in 38.9{\%} of patients, and correlated significantly with advanced pT status (P=0.019), poor prognosis [overall survival (P<0.0006) and disease-free survival (P<0.0002) of ESCC patients who had undergone curative surgery]. Positive staining for HIF-1α and p53 proteins in ESCC did not correlate with STC1 expression. The results showed marked induction of STC1 expression under hypoxia in cultured cells and in esophageal cancer cells and that overexpression of STC1 was an independent prognostic factor in patients with esophageal cancer who had undergone curative surgery. STC1 is a potentially useful biomarker for ESCC treatment.",
author = "Mitsuhiro Shirakawa and Yoshiyuki Fujiwara and Yurika Sugita and Moon, {Jeong Ho} and Shuji Takiguchi and Kiyokazu Nakajima and Hiroshi Miyata and Makoto Yamasaki and Masaki Mori and Yuichiro Doki",
year = "2012",
month = "4",
day = "1",
doi = "10.3892/or.2011.1607",
language = "English",
volume = "27",
pages = "940--946",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma

AU - Shirakawa, Mitsuhiro

AU - Fujiwara, Yoshiyuki

AU - Sugita, Yurika

AU - Moon, Jeong Ho

AU - Takiguchi, Shuji

AU - Nakajima, Kiyokazu

AU - Miyata, Hiroshi

AU - Yamasaki, Makoto

AU - Mori, Masaki

AU - Doki, Yuichiro

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Stanniocalcin-1 (STC1) is a secreted glycoprotein hormone and highly expressed in various types of human malignancies. Although evidence points to the role of STC1 in human cancers, the clinical significance of STC1 expression in esophageal cancer has not been well established. Quantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry were performed to assess the expression of STC1 in the cancer cell line TE8 and esophageal cancer tissues from 229 esophageal squamous cell carcinomas (ESCC). Surgically-resected tissue sections were immunostained for potential regulators of STC1 expression, hypoxia-inducible factor-1α (HIF-1α) and p53. Marked increase in STC1 mRNA and protein expression was noted in TE8 cells cultured under hypoxic conditions. Overexpression of STC1 mRNA was noted in ESCC tumors compared to normal counterparts. Positive immunohistochemical staining for STC1 protein was observed in 38.9% of patients, and correlated significantly with advanced pT status (P=0.019), poor prognosis [overall survival (P<0.0006) and disease-free survival (P<0.0002) of ESCC patients who had undergone curative surgery]. Positive staining for HIF-1α and p53 proteins in ESCC did not correlate with STC1 expression. The results showed marked induction of STC1 expression under hypoxia in cultured cells and in esophageal cancer cells and that overexpression of STC1 was an independent prognostic factor in patients with esophageal cancer who had undergone curative surgery. STC1 is a potentially useful biomarker for ESCC treatment.

AB - Stanniocalcin-1 (STC1) is a secreted glycoprotein hormone and highly expressed in various types of human malignancies. Although evidence points to the role of STC1 in human cancers, the clinical significance of STC1 expression in esophageal cancer has not been well established. Quantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry were performed to assess the expression of STC1 in the cancer cell line TE8 and esophageal cancer tissues from 229 esophageal squamous cell carcinomas (ESCC). Surgically-resected tissue sections were immunostained for potential regulators of STC1 expression, hypoxia-inducible factor-1α (HIF-1α) and p53. Marked increase in STC1 mRNA and protein expression was noted in TE8 cells cultured under hypoxic conditions. Overexpression of STC1 mRNA was noted in ESCC tumors compared to normal counterparts. Positive immunohistochemical staining for STC1 protein was observed in 38.9% of patients, and correlated significantly with advanced pT status (P=0.019), poor prognosis [overall survival (P<0.0006) and disease-free survival (P<0.0002) of ESCC patients who had undergone curative surgery]. Positive staining for HIF-1α and p53 proteins in ESCC did not correlate with STC1 expression. The results showed marked induction of STC1 expression under hypoxia in cultured cells and in esophageal cancer cells and that overexpression of STC1 was an independent prognostic factor in patients with esophageal cancer who had undergone curative surgery. STC1 is a potentially useful biomarker for ESCC treatment.

UR - http://www.scopus.com/inward/record.url?scp=84856566829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856566829&partnerID=8YFLogxK

U2 - 10.3892/or.2011.1607

DO - 10.3892/or.2011.1607

M3 - Article

C2 - 22200953

AN - SCOPUS:84856566829

VL - 27

SP - 940

EP - 946

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 4

ER -